S&P 500   3,828.68 (+0.23%)
DOW   31,324.44 (+0.17%)
QQQ   310.46 (+0.42%)
AAPL   122.61 (+0.45%)
MSFT   230.21 (+1.16%)
FB   262.20 (+2.66%)
GOOGL   2,049.00 (+1.87%)
TSLA   648.56 (-0.71%)
AMZN   3,044.54 (+1.32%)
NVDA   508.57 (-0.71%)
BABA   234.04 (-0.94%)
CGC   31.93 (-3.94%)
GE   13.61 (+1.26%)
MU   86.59 (-2.83%)
NIO   40.90 (-1.52%)
AMD   80.32 (-0.67%)
T   29.06 (+1.18%)
F   12.13 (-0.33%)
ACB   10.15 (-2.96%)
DIS   189.35 (-1.51%)
BA   229.88 (+0.58%)
NFLX   525.50 (+0.92%)
PFE   34.88 (+1.42%)
S&P 500   3,828.68 (+0.23%)
DOW   31,324.44 (+0.17%)
QQQ   310.46 (+0.42%)
AAPL   122.61 (+0.45%)
MSFT   230.21 (+1.16%)
FB   262.20 (+2.66%)
GOOGL   2,049.00 (+1.87%)
TSLA   648.56 (-0.71%)
AMZN   3,044.54 (+1.32%)
NVDA   508.57 (-0.71%)
BABA   234.04 (-0.94%)
CGC   31.93 (-3.94%)
GE   13.61 (+1.26%)
MU   86.59 (-2.83%)
NIO   40.90 (-1.52%)
AMD   80.32 (-0.67%)
T   29.06 (+1.18%)
F   12.13 (-0.33%)
ACB   10.15 (-2.96%)
DIS   189.35 (-1.51%)
BA   229.88 (+0.58%)
NFLX   525.50 (+0.92%)
PFE   34.88 (+1.42%)
S&P 500   3,828.68 (+0.23%)
DOW   31,324.44 (+0.17%)
QQQ   310.46 (+0.42%)
AAPL   122.61 (+0.45%)
MSFT   230.21 (+1.16%)
FB   262.20 (+2.66%)
GOOGL   2,049.00 (+1.87%)
TSLA   648.56 (-0.71%)
AMZN   3,044.54 (+1.32%)
NVDA   508.57 (-0.71%)
BABA   234.04 (-0.94%)
CGC   31.93 (-3.94%)
GE   13.61 (+1.26%)
MU   86.59 (-2.83%)
NIO   40.90 (-1.52%)
AMD   80.32 (-0.67%)
T   29.06 (+1.18%)
F   12.13 (-0.33%)
ACB   10.15 (-2.96%)
DIS   189.35 (-1.51%)
BA   229.88 (+0.58%)
NFLX   525.50 (+0.92%)
PFE   34.88 (+1.42%)
S&P 500   3,828.68 (+0.23%)
DOW   31,324.44 (+0.17%)
QQQ   310.46 (+0.42%)
AAPL   122.61 (+0.45%)
MSFT   230.21 (+1.16%)
FB   262.20 (+2.66%)
GOOGL   2,049.00 (+1.87%)
TSLA   648.56 (-0.71%)
AMZN   3,044.54 (+1.32%)
NVDA   508.57 (-0.71%)
BABA   234.04 (-0.94%)
CGC   31.93 (-3.94%)
GE   13.61 (+1.26%)
MU   86.59 (-2.83%)
NIO   40.90 (-1.52%)
AMD   80.32 (-0.67%)
T   29.06 (+1.18%)
F   12.13 (-0.33%)
ACB   10.15 (-2.96%)
DIS   189.35 (-1.51%)
BA   229.88 (+0.58%)
NFLX   525.50 (+0.92%)
PFE   34.88 (+1.42%)
Log in
OTCMKTS:CTYX

Curative Biotechnology Stock Forecast, Price & News

$0.19
+0.02 (+11.56 %)
(As of 03/3/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.17
Now: $0.19
$0.20
50-Day Range
$0.04
MA: $0.11
$0.20
52-Week Range
$0.00
Now: $0.19
$0.22
Volume4.50 million shs
Average Volume4.38 million shs
Market Capitalization$69.49 million
P/E RatioN/A
Dividend YieldN/A
Beta-31.94
Curative Biotechnology, Inc., doing business as Connectyx, a development-stage biomedical company, focuses on novel treatments for rare diseases. The company focuses on therapies with potentially accelerated development paths as a result of the disease, the nature of the therapeutic itself, or the stage of clinical development. Its pipeline candidates include CURB906, an antibody drug conjugate for targeting CD56 positive brain tumors; and IMT504, a novel immune therapy to treat rabies. Curative Biotechnology, Inc. was founded in 1995 and is based in Boca Raton, Florida.

Industry, Sector and Symbol

Industry Miscellaneous health & allied services, not elsewhere classified
Sub-IndustryN/A
Current SymbolOTCMKTS:CTYX
CUSIPN/A
CIKN/A
Phone800-526-8006
EmployeesN/A
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Market Cap$69.49 million
Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.00 out of 5 stars

Business Services Sector

412th out of 442 stocks

Miscellaneous Health & Allied Services, Not Elsewhere Classified Industry

24th out of 25 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$0.19
+0.02 (+11.56 %)
(As of 03/3/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive CTYX News and Ratings via Email

Sign-up to receive the latest news and ratings for CTYX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Curative Biotechnology (OTCMKTS:CTYX) Frequently Asked Questions

What stocks does MarketBeat like better than Curative Biotechnology?

Wall Street analysts have given Curative Biotechnology a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Curative Biotechnology wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Curative Biotechnology?

Curative Biotechnology saw a decrease in short interest in the month of February. As of February 12th, there was short interest totaling 53,700 shares, a decrease of 63.8% from the January 28th total of 148,300 shares. Based on an average trading volume of 11,035,200 shares, the days-to-cover ratio is presently 0.0 days.
View Curative Biotechnology's Short Interest
.

Who are Curative Biotechnology's key executives?

Curative Biotechnology's management team includes the following people:
  • Mr. Paul M. Michaels, Pres, Chairman & CEO
  • Dr. Barry A. Ginsberg B.A., B.S., Chief Strategy Officer & Vice Chairman
  • Mr. Pam Bisikirski, VP of Communications

Who are some of Curative Biotechnology's key competitors?

What is Curative Biotechnology's stock symbol?

Curative Biotechnology trades on the OTCMKTS under the ticker symbol "CTYX."

How do I buy shares of Curative Biotechnology?

Shares of CTYX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Curative Biotechnology's stock price today?

One share of CTYX stock can currently be purchased for approximately $0.19.

How much money does Curative Biotechnology make?

Curative Biotechnology has a market capitalization of $69.49 million.

What is Curative Biotechnology's official website?

The official website for Curative Biotechnology is www.connectyx.com.

Where are Curative Biotechnology's headquarters?

Curative Biotechnology is headquartered at 49 SW Flagler Avenue Suite 302, Stuart FL, 34994.

How can I contact Curative Biotechnology?

Curative Biotechnology's mailing address is 49 SW Flagler Avenue Suite 302, Stuart FL, 34994. The company can be reached via phone at 800-526-8006 or via email at [email protected]


This page was last updated on 3/4/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.